(Q44545741)

4 December 2017

title

Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis (English)

1 reference

4 December 2017

1 reference

1 reference

Yan Wang

1

1 reference

4 December 2017

Xin-Ming Jia

2

1 reference

4 December 2017

Jian-Hui Jia

3

1 reference

4 December 2017

Ming-Bang Li

4

1 reference

4 December 2017

Ying-Ying Cao

5

1 reference

4 December 2017

Ping-Hui Gao

6

1 reference

4 December 2017

Wan-Qing Liao

7

1 reference

4 December 2017

Yong-Bing Cao

8

1 reference

4 December 2017

Yuan-Ying Jiang

9

1 reference

4 December 2017

publication date

27 April 2009

1 reference

Clinical and Experimental Pharmacology and Physiology

4 December 2017

published in

1 reference

4 December 2017

volume

36

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

e40-6

1 reference

Direct comparison of the pharmacodynamics of four antifungal drugs in a mouse model of disseminated candidiasis using microbiological assays of serum drug concentrations

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05187.X

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05187.X

Fluconazole: optimized antifungal therapy based on pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05187.X

The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05187.X

10.1111/J.1440-1681.2009.05187.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference